Akso Health Group (NASDAQ: AHG) director Liu Wenjuan files initial Form 3

Rhea-AI Filing Summary

Akso Health Group director files initial ownership report

Akso Health Group director Liu Wenjuan has filed an initial statement of beneficial ownership as required for new insiders. The filing shows no reported purchases, sales, gifts, or other transactions, and no derivative positions are listed in this excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 03/27/2026 - 06:46 AM Learn about SEC filing dates

FAQ

What does Akso Health Group (AHG) Form 3 for Liu Wenjuan disclose?

The Form 3 for Liu Wenjuan at Akso Health Group discloses her status as a director and serves as an initial statement of beneficial ownership. It reports no share purchases, sales, gifts, or derivative transactions in the data shown.

Does the Akso Health Group (AHG) Form 3 show any insider buying or selling?

No insider buying or selling is shown. The transaction summary for Liu Wenjuan reports zero purchases, zero sales, zero gifts, and no derivative exercises, indicating no reportable trading activity in the period covered by this initial filing excerpt.

Are there any derivative securities reported for Liu Wenjuan in AHG's Form 3?

No derivative securities are reported. The derivative summary is empty and derivativeTransactionCount is zero, indicating no listed options, warrants, or other derivative positions for Liu Wenjuan in the provided portion of the Form 3 filing.

What role does Liu Wenjuan hold at Akso Health Group (AHG) in this Form 3?

The Form 3 identifies Liu Wenjuan as a director of Akso Health Group. She is not reported as an officer or ten percent owner in the metadata, so the filing focuses on her board-level insider reporting obligations.

Why is a Form 3 filed for Akso Health Group (AHG) director Liu Wenjuan?

Form 3 is filed to provide an initial statement of beneficial ownership when a person becomes an insider, such as a director. This filing starts the official record of Liu Wenjuan’s reportable holdings and future transactions in Akso Health Group securities.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Liu Wenjuan

(Last) (First) (Middle)

ROOM 8201-4-4(A), 2ND FLOOR

QIANTONGYUAN BUILDING

(Street)

QINGDAO 00000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/27/2026

3. Issuer Name and Ticker or Trading Symbol
Akso Health Group [ AHG ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	Wenjuan Liu	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)